BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 817399)

  • 21. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE; Farrington CA; Wall GC; Belz MM
    Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hyperkalemia in renal insufficiency with cation exchange resin. Experience with use of sodium polystyrene sulfonate].
    Osawa A; Okoshi M; Higuchi J; Yamayoshi W
    Hinyokika Kiyo; 1969 Sep; 15(9):645-51. PubMed ID: 5388724
    [No Abstract]   [Full Text] [Related]  

  • 23. Inflammatory Pseudotumor Containing Kayexalate Crystals: A Case Report and Review of the Literature.
    Romano RC; Thirumala S; Cushman WH; Mounajjed T
    Int J Surg Pathol; 2014 Aug; 22(5):464-9. PubMed ID: 24178951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hyperkalemia: something old, something new.
    Sterns RH; Grieff M; Bernstein PL
    Kidney Int; 2016 Mar; 89(3):546-54. PubMed ID: 26880451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hyperkalemia associated with renal insufficiency--clinical effects and side reactions of positive-ion-exchange resins, sodium polystyrene sulfonate (Kayexalate)].
    Takasu T
    Nihon Rinsho; 1970 Jul; 28(7):1941-6. PubMed ID: 5466528
    [No Abstract]   [Full Text] [Related]  

  • 26. Sodium polystyrene sulfonate (Kayexalate).
    Noerr B
    Neonatal Netw; 1993 Apr; 12(3):77-9. PubMed ID: 8474418
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of sodium polystyrene sulfonate in sorbitol in the United States, 1985-1989.
    Gerstman BB; Platt R
    Am J Kidney Dis; 1991 Nov; 18(5):619-20. PubMed ID: 1951347
    [No Abstract]   [Full Text] [Related]  

  • 28. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?
    Sterns RH; Rojas M; Bernstein P; Chennupati S
    J Am Soc Nephrol; 2010 May; 21(5):733-5. PubMed ID: 20167700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium-alkali syndrome due to vitamin D administration and magnesium oxide administration.
    Hanada S; Iwamoto M; Kobayashi N; Ando R; Sasaki S
    Am J Kidney Dis; 2009 Apr; 53(4):711-4. PubMed ID: 19185403
    [No Abstract]   [Full Text] [Related]  

  • 30. Intestinal obstruction due to kayexalate in a patient concurrently treated with aluminum hydroxide and morphine sulfate.
    Foresti V
    Clin Nephrol; 1994 Apr; 41(4):252. PubMed ID: 8026121
    [No Abstract]   [Full Text] [Related]  

  • 31. The Successful Treatment of Sodium Polystyrene Sulfonate-induced Enteritis Diagnosed by Small Bowel Endoscopy.
    Okayama K; Hirata Y; Kumai D; Yamamoto Y; Kojima Y; Kanno T; Ikeuchi H; Mochizuki H; Takada H; Sobue S
    Intern Med; 2018 Jun; 57(11):1577-1581. PubMed ID: 29321412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium Polystyrene Sulfonate in Sorbitol-Induced Colonic Ulcerations.
    Bansal R; Abdu A; Arya V
    Am J Gastroenterol; 2018 Jan; 113(1):11. PubMed ID: 29311732
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sodium polystyrene sulfonate (Resonium A) as possible cause of rectal blood loss].
    Schiere S; Karrenbeld A; Tulleken JE; van der Werf TS; Zijlstra JG
    Ned Tijdschr Geneeskd; 1997 Nov; 141(44):2127-9. PubMed ID: 9550776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kayexalate: a new cause of neonatal bowel opacification.
    Sherman S; Friedman AP; Berdon WE; Haller JO
    Radiology; 1981 Jan; 138(1):63-4. PubMed ID: 7455099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rectally administered sodium polystyrene sulfonate.
    Gales MA; Gales BJ; Dyer ME; Orr SR
    Am J Health Syst Pharm; 1995 Dec; 52(24):2813-5. PubMed ID: 8748567
    [No Abstract]   [Full Text] [Related]  

  • 36. From hyperkalemia to ischemic colitis: a resinous way.
    Tapia C; Schneider T; Manz M
    Clin Gastroenterol Hepatol; 2009 Aug; 7(8):e46-7. PubMed ID: 19281864
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost-utility analysis of sodium polystyrene sulfonate vs. potential alternatives for chronic hyperkalemia.
    Little DJ; Nee R; Abbott KC; Watson MA; Yuan CM
    Clin Nephrol; 2014 Apr; 81(4):259-68. PubMed ID: 24656316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colonic necrosis due to sodium polystyrene sulfate (Kayexalate).
    Bomback AS; Woosley JT; Kshirsagar AV
    Am J Emerg Med; 2009 Jul; 27(6):753.e1-2. PubMed ID: 19751641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypercalcemic crises in patients with chronic kidney failure due to calcium-containing ion-exchangers, antacids and other drugs].
    Graben N; Cremer W; Anlauf M; Bock KD
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1505-8. PubMed ID: 1030032
    [No Abstract]   [Full Text] [Related]  

  • 40. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia.
    Watson M; Abbott KC; Yuan CM
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1723-6. PubMed ID: 20798253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.